Kingsley Taft > Goodwin > Boston, United States > Lawyer Profile

Goodwin
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
Kingsley Taft photo

Position

Partner

Career

Kingsley Taft is a senior partner and co-chair of Goodwin’s Life Sciences group and a former member of the Allocations Committee. He represents emerging to mature life sciences companies in all aspects of their business and legal affairs, including company formation, venture financings, strategic alliances, M&A, IPOs and other capital market transactions, and other financing and commercial transactions. Kingsley has extensive experience in assisting clients with JVs, strategic alliances, licenses, and collaborations.

Kingsley has been recognized as a leading life sciences attorney by numerous legal guides. He has been annually ranked for more than 15 years in Chambers USA: America’s Leading Lawyers for Business (Nationwide, Life Sciences: Corporate/Commercial — Band 1). Kingsley was inducted into the LMG Life Sciences Hall of Fame, named a Biotechnology and Life Sciences Lawyer of the Year in 2022 by The Best Lawyers in America and named a Life Sciences Thought Leader by Who’s Who Legal – Global Elite.

Education

JD, 1997, Harvard Law School (magna cum laude) / PhD, Chemistry, 1993, Massachusetts Institute of Technology / BS, Chemistry, 1989, Yale University (magna cum laude)

Lawyer Rankings

United States > Intellectual property > Patents: licensing

Working closely with companies at all stages of growth, in both US and foreign jurisdictions, Goodwin is lauded for its licensing, technology transactions, patent enforcement, prosecution and counseling. Capable of acting in various industries, clients span tech, life sciences, private equity, and financial services. In Boston Catherine McCarty co-heads the IP practice group, bringing expertise in IP to help clients in pharma and chemistry matters protect their innovations. Silicon Valley’s James Riley co-heads the group and frequently represents emerging growth tech companies and venture capital firms in licensing matters. Adept in technology, data and IP transactions is Boston-based lawyer Stephen Charkoudian. Kingsley Taft is well-versed in supporting emerging to mature life science companies. Washington DC’s Noelle Dubiansky possesses broad capabilities in IP including licensing and commercial undertakings for a diverse clientele including biotech, pharma and medical devices. Bethany Withers specializes in tech data, publicity rights and IP matters. Unless otherwise stated, all lawyers are based in Boston.

United States > Healthcare > Life sciences

(Leading partners)

Kingsley Taft – Goodwin

Goodwin’s global practice advises biotech, pharma, and healthcare companies, along with life science venture capital and investment firms. The growing practice supports clients in matters as wide-ranging as regulatory compliance, IP and M&A. The team’s representation of Prime Medicine in its $3.5bn deal with Bristol Myers Squibb evidences its excellence in research collaboration and license agreement matters. The practice is headed by Kingsley Taft, vastly experienced in commercial, financing and capital market transactions, and Mitchell Bloom, who specializes in emerging companies and life sciences investors. Both in Boston, transactional lawyer Robert Puopolo and Marishka DeToy, who focuses on capital markets and corporate matters, are key figures in the practice. In DC, Steven Tjoe focuses on product development strategies and FDA regulatory counseling. Arriving on the Boston-based team from Cooley LLP are Joshua Rottner, venture capital and growth equity funds specialist, and Michael McGrail, focused on medical devices and life sciences. Other key hires include litigation expert Michael Siekman, arriving in Boston from McDermott Will & Emery LLP, M&A specialist Amanda Gill, from Paul, Weiss, Rifkind, Wharton & Garrison LLP, and IP lawyer Carl Morales, from Fenwick & West LLP; the latter two are based in New York.